Journal of Peking University(Health Sciences) >
Clinical characteristics and treatment in adults and children with histiocytic necroti-zing lymphadenitis
Received date: 2024-01-18
Online published: 2024-06-12
Objective: To analyze the clinical data of histiocytic necrotizing lymphadenitis(HNL), comparing the similarities and differences between children and adults, to deepen the understanding of the disease by clinical physicians, and to improve diagnostic rate and reduce misdiagnosis and mistreatment. Methods: The clinical data of hospitalized patients with histiocytic necrotizing lymphadenitis diagnosed by biopsy from January 2010 to August 2023 in Peking University First Hospital were collec-ted, and the clinical features, laboratory examinations, pathological features, treatments with antibiotics and glucocorticoids, and prognosis of histiocytic necrotic lymphadenitis were analyzed. Grouped based on age, the differences of clinical characteristics, laboratory tests, treatment, and prognosis between the children group (< 16 years old) and the adult group (≥16 years old) were compared. Results: Among the 81 enrolled patients, there were 42 males and 39 females. The median age was 21(14, 29) years, the median duration of disease was 20.0(13.0, 30.0) days, and the median length of hospital stay was 13.0 (10.0, 15.0) days. The first symptoms were fever, lymphadenopathy, and both. All the patients had enlarged lymph nodes with different parts and sizes, 96.3% (78 of 81) of the patients had cervical lymphadenopathy, 50.6% (41 of 81) had bilateral cervical lymphadenopathy, 55.6% (45 of 81) had supraclavicular, axillary or inguinal lymphadenopathy, and the median lymph node diameter was 20.0(20.0, 30.0) mm. Only one patient had no fever, the other 80 patients had fever, the median peak body temperature was 39.0(38.0, 39.8) ℃. Accompanying symptoms: rash (8.6%, 7/81), fatigue (34.6%, 28/81), night sweating (8.6%, 7/81), chills (25.3%, 25/81), muscle soreness (13.6%, 11/81), and joint pain (6.2%, 5/81). There were 17 cases (21.0%, 17/81) of hepatosplenomegaly, of which 12 cases (70.6%, 12/17) were splenomegaly. 68.8%(55/80) of patients had a decrease in white blood cell (WBC) count, with 47.5%(38/80)increased in lymphocyte(LY)proportion, 53.4%(39/73) increased in high-sensitivity C-reactive protein(CRP), 79.2%(57/72) increased in erythrocyte sedimentation rate(ESR), 22.2%(18/81) increased in alanine transaminase(ALT), 27.2%(22/81) elevated in aspartate transaminase(AST), and 81.6%(62/76) elevated in lactate dehydrogenase(LDH). All the 81 patients underwent lymph node biopsy, and 77.8%(63/81) of the patients showed that most of the structures in the lymph nodes were destroyed or disappeared, and 16.0%(13/81) of the lymph nodes were still in existence, hyperplasia and normal lymph node were 1.2%(1/81) respectively, and 3.7%(3/81) had normal lymph node structures. Immunohistochemical staining was performed in 67 cases. The percentages of CD3+ and CD68(KP1)+ were respectively 97.0%(65/67), and MPO+ were 94.0%(63/67). In the study, 51 patients (63.0%, 51/81) were treated with glucocorticoid therapy after diagnosis. The median time for temperature to return to normal was 1.0(1.0, 4.0) days after glucocorticoid therapy. when the glucocorticoid treatment worked best, the body temperature could drop to normal on the same day. There were significant differences in length of stay, predisposing factors, chills, the rate of increase in high-sensitivity CRP, antibiotic and glucocorticoid treatment between the adults and children groups (P < 0.05). Conclusion: In clinical practice, if there are cases with unexplained fever, superficial lymph node enlargement, and reduced white blood cells as clinical characteristics, and general antibiotics treatment is ineffective, histiocytic necrotic lymphadenitis should be considered. Lymph node biopsy should be performed as early as possible to clarify the diagnosis, reduce misdiagnosis and mistreatment, and symptomatic treatment should be the main treatment. Glucocorticoids therapy has a definite therapeutic effect.
Key words: Histiocytic necrotic lymphadenitis; Adult; Children
Xiuwen FEI , Si LIU , Bo WANG , Aimei DONG . Clinical characteristics and treatment in adults and children with histiocytic necroti-zing lymphadenitis[J]. Journal of Peking University(Health Sciences), 2024 , 56(3) : 533 -540 . DOI: 10.19723/j.issn.1671-167X.2024.03.022
| 1 | Bosch X , Guilabea A , Miquel R , et al. Enigmatic Kikucli-Fujimoto disease: A comprehensive review[J]. Am J Clin Pathol, 2004, 122 (1): 141- 152. |
| 2 | Ohshima K , Kikuchi M , Sumiyoshi Y , et al. Proliferating cells in histiocytic necrotizing lymphadenitis[J]. Virchows Arch B Cell Pathol Incl Mol Pathol, 1991, 61 (2): 97- 100. |
| 3 | 杨进孙, 王文节, 杨江华. 组织细胞坏死性淋巴结炎25例临床及病理特征分析[J]. 皖南医学院学报, 2018, 37 (1): 19- 21. |
| 4 | Lebe E . Kikuchi-Fujimoto disease[J]. Kulak Burun Bogaz Ihtis Derg, 2014, 24 (3): 164- 167. |
| 5 | 王艳, 巩小丽, 黄有清, 等. 组织细胞坏死性淋巴结炎误诊误治讨论[J]. 临床误诊误治, 2015, 28 (2): 31- 33. |
| 6 | Pepe F , Disma S , Teodoro C , et al. Kikuchi-Fujimoto disease: A clinicopathologic update[J]. Pathologica, 2016, 108 (3): 120- 129. |
| 7 | Xu Z , Liu Y , Li H , et al. Detection of mycobacterial and viral DNA in Kikuchi-Fujimoto disease: An analysis of 153 Chinese pediatric cases[J]. Sci China Life Sci, 2017, 60 (7): 775- 777. |
| 8 | Hall LD , Eminger LA , Hesterman KS , et al. Epstein-Barr virus: Dermatologic associations and implications: Part Ⅰ. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders[J]. J Am Acad Dermatol, 2015, 72 (1): 1- 19. |
| 9 | Deaver D , Horna P , Cualing H , et al. Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease[J]. Cancer Control, 2014, 21 (4): 313- 321. |
| 10 | Chong Y , Kang CS . Causative agents of Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): A meta analysis[J]. Int J Pediatr Otorhinolaryngol, 2014, 78 (11): 1890- 1897. |
| 11 | Feder HM Jr , Liu J , Rezuke WN . Kikuchi disease in connecticut[J]. J Pediatr, 2014, 164 (1): 196- 200. |
| 12 | Fiorella ML , Gelardi M , Marzullo A , et al. Kikuchi-Fujimoto disease: An uncommon cause of neck swelling[J]. Eur Arch Otorhinolaryngol, 2017, 274 (3): 1761- 1764. |
| 13 | Dalugama C , Gawarammana IB . Fever with lym-phadenopathy: Kikuchi-Fujimoto disease, a great masquerader[J]. J Med Case Rep, 2017, 11 (1): 349. |
| 14 | Jung IY , Ann HW , Kim JJ , et al. The incidence and clinical characteristics by gender differences in patients with Kikuchi-Fujimoto disease[J]. Medicine (Baltimore), 2017, 96 (11): e6332. |
| 15 | Perry AM , Choi SM . Kikuchi-Fujimoto disease: A review[J]. Arch Pathol Lab Med, 2018, 142 (11): 1341- 1346. |
| 16 | 王宁, 王尧, 王晓, 等. 51例菊池病患者临床资料回顾性分析[J]. 内科理论与实践, 2019, 14 (4): 214- 218. |
| 17 | Yen HR , Lin PY , Chuang WY , et al. Skin manifestations of Kikuchi-Fujimoto disease: Case report and review[J]. Eur J Pediatr, 2004, 163 (4/5): 210- 213. |
| 18 | 费秀文, 迟春花, 狄娜, 等. 组织增生坏死性淋巴结炎一例[J]. 中华全科医师杂志, 2020, 19 (3): 253- 255. |
| 19 | 刘改萍, 田芳. 组织细胞坏死性淋巴结炎9例临床病理及彩超变化的探讨[J]. 山西医科大学学报, 2006, 37 (4): 402- 404. |
| 20 | 郑杨. 组织细胞坏死性淋巴结炎的诊断、鉴别诊断及其治疗[J]. 中国医刊, 2010, 45 (12): 12- 15. |
| 21 | Dumas G , Prendki V , Haroche J , et al. Kikuchi-Fujimoto disease: Retrospective study of 91 case sand review of the literature[J]. Medicine (Baltimore), 2014, 93 (24): 372- 382. |
| 22 | 宋红杰, 马捷. 组织细胞坏死性淋巴结炎的研究进展[J]. 临床与实验病理学杂志, 2015, 31 (5): 569- 571. |
| 23 | Bezek S , Tucci V , Kalra S , et al. State of the globe: Time tore visit Kikuchi-Fujimoto disease[J]. J Glob Infect Dis, 2014, 6 (4): 139- 140. |
/
| 〈 |
|
〉 |